Holen Sie sich die Stockscreener-App
2.49
6.39%
-0.17
Schlusskurs vom Vortag:
$2.66
Offen:
$2.5845
24-Stunden-Volumen:
61,997
Relative Volume:
1.29
Marktkapitalisierung:
$46.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.35%
1M Leistung:
+2.47%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.46
$2.59
1-Wochen-Bereich:
$2.46
$2.7932
52-Wochen-Spanne:
$2.28
$12.50
Kalaris Therapeutics Inc Stock (KLRS) Company Profile
Firmenname
Kalaris Therapeutics Inc
Sektor
Branche
Telefon
650-249-2727
Adresse
628 MIDDLEFIELD ROAD, PALO ALTO
Vergleichen Sie KLRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KLRS
Kalaris Therapeutics Inc
|
2.49 | 49.75M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Kalaris Therapeutics Inc Stock (KLRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-23 | Fortgesetzt | Piper Sandler | Neutral |
| 2025-05-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-08 | Eingeleitet | William Blair | Outperform |
Kalaris Therapeutics Inc Aktie (KLRS) Neueste Nachrichten
Using R and stats models for Kalaris Therapeutics Inc. forecastingPortfolio Gains Summary & Real-Time Market Trend Scan - Newser
Is Kalaris Therapeutics Inc. Forming a Bottom Pattern [July 2025 Pullbacks]Technical Pattern Based Buy Signals - beatles.ru
Is Kalaris Therapeutics Inc. stock entering bullish territoryJuly 2025 Trends & Stock Portfolio Risk Management - Newser
Will Kalaris Therapeutics Inc. stock go up soon2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser
Can Kalaris Therapeutics Inc. hit a new high this monthQuarterly Profit Report & Weekly Watchlist for Consistent Profits - Newser
What makes Kalaris Therapeutics Inc. stock price move sharplyTechnical Setup and Return Forecast Engine - Newser
How Kalaris Therapeutics Inc. stock performs during market volatilityEarnings Recap Report & Capital Efficient Trade Techniques - Newser
What moving averages say about Kalaris Therapeutics Inc.Oversold Opportunity Scanner with RSI Data - Newser
Should I buy Kalaris Therapeutics Inc. stock before earnings [July 2025 EndofMonth]Free Daily Stock Momentum Reports - Newser
Using AI based signals to follow Kalaris Therapeutics Inc.Intelligent Trade Forecast With AI Analytics - Newser
Can swing trading help recover from Kalaris Therapeutics Inc. lossesPredictable Income Summary for Long-Term Trades - Newser
How to integrate Kalaris Therapeutics Inc. into portfolio analysis toolsLong Term Equity Screener with Safety Metrics - Newser
Using Ichimoku Cloud for Kalaris Therapeutics Inc. technicalsSmart Entry Watchlist with Daily Analysis - Newser
Will Kalaris Therapeutics Inc. bounce back from current supportFree Breakout Entry Signal Confirmation Tool - Newser
Automated trading signals detected on Kalaris Therapeutics Inc.Free Weekly Top Gainers Forecast Watchlist - Newser
Will earnings trigger a reversal in Kalaris Therapeutics Inc.Free Low Volatility Stable Growth Picks - Newser
Has Kalaris Therapeutics Inc. formed a bullish divergenceReal Time Alert System for Market Moves - Newser
Why Kalaris Therapeutics Inc. stock attracts strong analyst attentionIntelligent Trade Forecast With AI Analytics - Newser
Multi asset correlation models including Kalaris Therapeutics Inc.Real Time Trade Execution Alert Plan - Newser
Using economic indicators to assess Kalaris Therapeutics Inc. potentialChart Confirmation Setup with ROI Signals - Newser
Is Kalaris Therapeutics Inc. stock a good hedge against inflationAnnual Market Behavior and Sector Summary - Newser
Will Kalaris Therapeutics Inc. continue its uptrendMachine Learning Stock Price Forecast Tool - Newser
Kalaris KLRS 2025Q2 Earnings Preview Upside Potential on Analyst Price Target Predictions - AInvest
Should I buy Kalaris Therapeutics Inc. stock before earningsWatchlist Generator for Smart Money Signals - Newser
Applying Elliott Wave Theory to Kalaris Therapeutics Inc.Watchlist Summary for Active Day Traders - Newser
What analysts say about Kalaris Therapeutics Inc. stockHigh-yield trading alerts - Jammu Links News
How volatile is Kalaris Therapeutics Inc. stock compared to the marketUnlock powerful trading tools for investors - Jammu Links News
Finanzdaten der Kalaris Therapeutics Inc-Aktie (KLRS)
Es liegen keine Finanzdaten für Kalaris Therapeutics Inc (KLRS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):